Multiple mechanisms are involved in driving the efficacy of drug delivery. Drug particle size is one of the challenges as particles need to be delivered from the external environment, into the circulation or interstitial fluid and transiting the cell membranes for cellular internalisation. Small particles are presumably easier to be internalised, yet they are not…
Pharmaceutical Science Advances Template
Write in a clean editor, then format for Pharmaceutical Science Advances in one click — DocuGuru applies the official Elsevier template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Pharmaceutical Science Advances format
Pharmaceutical Science Advances is a peer-reviewed journal published by Elsevier, covering Nanoparticle-Based Drug Delivery, Drug Solubulity and Delivery Systems, Advanced Drug Delivery Systems.
| Publisher | Elsevier |
|---|---|
| Reference style | Numbered (Elsevier) Numbered — [1], [2] in the text [1] A. Smith, B. Jones, C. Lee, A representative article title, Pharmaceutical Science Advances 12 (2023) 45–58.
Formats any DOI in Pharmaceutical Science Advances style. No sign-up. |
| Publishes research in | Nanoparticle-Based Drug Delivery Drug Solubulity and Delivery Systems Advanced Drug Delivery Systems Computational Drug Discovery Methods Autophagy in Disease and Therapy |
| ISSN | 2773-2169 |
| Citation impact (2-yr) | 5.57 |
| h-index | 17 |
| i10-index | 27 |
| Total citations | 916 |
| Open access | Yes |
| Top institutions publishing here | Shandong University |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Pharmaceutical Science Advances per year
Citation impact of Pharmaceutical Science Advances by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Pharmaceutical Science Advances
Alzheimer's disease (AD) is a progressive neurodegenerative disease characterized by memory loss, cognitive decline, impairment in activities of daily living, and loss of independent function. Cognitive decline and brain shrinkage, particularly hippocampal atrophy, are associated with the accumulation of tau proteins. They cause inflammation, amyloid plaque deposition, neuronal loss, temporofrontal cortex atrophy, aberrant protein fragment…
Natural products (NPs) exhibit diverse chemical structures and biological activities that make them valuable sources for drug discovery. With advancements in computational technology, computation-enabled natural drug discovery is gaining increasing significance, with NP databases playing a pivotal role. In light of this, we first summarize the key features of NP databases, including structural data, property…
Traditional chemotherapy is often accompanied by off-target toxicity, resulting in adverse side effects and driving the development of targeted therapies. Targeted drug conjugates (TDCs) typically comprise targeting ligands, such as specific antibodies, peptides, or small molecules, attached to a cytotoxic agent via a chemical linker. In this study, we briefly discussed the molecular aspects of…
Chronic and severe inflammation results in many diseases and disorders in humans. Currently, available conventional anti-inflammatory drugs have numerous mild-to-severe side effects. Thus, there is a need for safe, effective, affordable, and alternative anti-inflammatory drugs. This study aimed to evaluate the anti-inflammatory effect of sclareol (SCL), a diterpene alcohol that is the principal ingredient in…